TD Private Client Wealth LLC Has $3.36 Million Stock Holdings in Colgate-Palmolive (NYSE:CL)

TD Private Client Wealth LLC grew its position in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 35.0% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 32,320 shares of the company's stock after acquiring an additional 8,379 shares during the quarter. TD Private Client Wealth LLC's holdings in Colgate-Palmolive were worth $3,355,000 at the end of the most recent quarter.

Other large investors have also modified their holdings of the company. Acadian Asset Management LLC raised its stake in Colgate-Palmolive by 108.4% during the 2nd quarter. Acadian Asset Management LLC now owns 5,682,280 shares of the company's stock valued at $551,367,000 after acquiring an additional 2,955,442 shares in the last quarter. FMR LLC raised its stake in Colgate-Palmolive by 65.6% during the 3rd quarter. FMR LLC now owns 6,749,275 shares of the company's stock valued at $700,642,000 after acquiring an additional 2,674,807 shares in the last quarter. Massachusetts Financial Services Co. MA raised its stake in Colgate-Palmolive by 40.7% during the 2nd quarter. Massachusetts Financial Services Co. MA now owns 8,969,498 shares of the company's stock valued at $870,400,000 after acquiring an additional 2,593,313 shares in the last quarter. Barclays PLC raised its stake in Colgate-Palmolive by 38.7% during the 3rd quarter. Barclays PLC now owns 7,644,189 shares of the company's stock valued at $793,542,000 after acquiring an additional 2,132,747 shares in the last quarter. Finally, State Street Corp raised its stake in Colgate-Palmolive by 3.8% during the 3rd quarter. State Street Corp now owns 48,436,276 shares of the company's stock valued at $5,028,170,000 after acquiring an additional 1,784,411 shares in the last quarter. Institutional investors and hedge funds own 80.41% of the company's stock.

Insider Buying and Selling at Colgate-Palmolive

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the business's stock in a transaction dated Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the sale, the chief financial officer now owns 36,726 shares of the company's stock, valued at $3,456,283.86. The trade was a 55.29 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 0.37% of the company's stock.

Colgate-Palmolive Stock Up 0.9 %

NYSE CL traded up $0.83 on Thursday, reaching $93.59. The stock had a trading volume of 1,244,198 shares, compared to its average volume of 4,368,864. The business has a 50 day moving average price of $95.97 and a 200 day moving average price of $98.62. The company has a current ratio of 1.04, a quick ratio of 0.68 and a debt-to-equity ratio of 9.46. Colgate-Palmolive has a 1 year low of $75.50 and a 1 year high of $109.30. The company has a market capitalization of $76.46 billion, a price-to-earnings ratio of 26.58, a P/E/G ratio of 3.36 and a beta of 0.43.

Colgate-Palmolive Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st will be paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 2.14%. Colgate-Palmolive's dividend payout ratio (DPR) is currently 57.31%.

Analysts Set New Price Targets

CL has been the topic of several recent analyst reports. Stifel Nicolaus downgraded Colgate-Palmolive from a "buy" rating to a "hold" rating and cut their target price for the company from $105.00 to $101.00 in a research note on Monday, October 28th. Wells Fargo & Company dropped their price objective on Colgate-Palmolive from $100.00 to $92.00 and set an "underweight" rating on the stock in a research note on Monday, October 28th. UBS Group boosted their price objective on Colgate-Palmolive from $119.00 to $122.00 and gave the stock a "buy" rating in a research note on Wednesday, September 4th. JPMorgan Chase & Co. boosted their price objective on Colgate-Palmolive from $113.00 to $114.00 and gave the stock an "overweight" rating in a research note on Friday, October 11th. Finally, TD Cowen dropped their price objective on Colgate-Palmolive from $115.00 to $110.00 and set a "buy" rating on the stock in a research note on Monday, October 28th. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and thirteen have issued a buy rating to the stock. According to data from MarketBeat.com, Colgate-Palmolive has a consensus rating of "Moderate Buy" and an average price target of $105.11.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.